Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/11000/35149
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorHofmann, Michael-
dc.contributor.authorGarcía, Mauricio A.-
dc.contributor.authorAl-Gousous, Jozef-
dc.contributor.authorRuiz Picazo, Alejandro-
dc.contributor.authorThieringer, Florian-
dc.contributor.authorNguyen, Mai-
dc.contributor.authorMansson, Wiking-
dc.contributor.authorGalle, Peter R.-
dc.contributor.authorLangguth, Peter-
dc.contributor.otherDepartamentos de la UMH::Ingenieríaes_ES
dc.date.accessioned2025-01-22T12:12:51Z-
dc.date.available2025-01-22T12:12:51Z-
dc.date.created2020-02-
dc.identifier.citationEuropean Journal of Pharmaceutics and Biopharmaceutics Volume 149, April 2020, Pages 229-237es_ES
dc.identifier.issn1873-3476-
dc.identifier.issn0378-5173-
dc.identifier.urihttps://hdl.handle.net/11000/35149-
dc.description.abstractTwo ibuprofen suspension formulations were investigated for their dissolution in various bicarbonate, phosphate and acetate buffers. Phosphate and acetate gave faster release than bicarbonate at comparable molarities. Nevertheless, mass transport modelling using the reversible non-equilibrium (RNE) approach enabled the calculation of phosphate molarities that gave good matches to physiological bicarbonate in terms of ibuprofen dissolution. This shows that developing surrogate buffers for bicarbonate that are devoid of the technical difficulties associated with the bicarbonate-CO2 systems is possible. In addition, the intestinal dissolution kinetics of the tested suspensions were determined by applying compartmental pharmacokinetic modelling to plasma profiles that were previously obtained for these suspensions in an in vivo study performed on healthy human volunteers. The in vitro dissolution profiles in bicarbonate compared reasonably well with the profiles representing the in vivo intestinal dissolution kinetics of the tested suspensions when applied to healthy human volunteers in a pharmacokinetic study. This shows the possible potential toward extending biowaivers so that they include BCS class IIa compounds.es_ES
dc.formatapplication/pdfes_ES
dc.format.extent9es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectDissolutiones_ES
dc.subjectBicarbonatees_ES
dc.subjectBufferes_ES
dc.subjectIntestinees_ES
dc.subjectBiowaiverses_ES
dc.subject.otherCDU::6 - Ciencias aplicadas::62 - Ingeniería. Tecnologíaes_ES
dc.titleIn vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditionses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.ejpb.2020.02.009es_ES
Aparece en las colecciones:
Artículos Ingeniería


no-thumbnailVer/Abrir:

 5 In vitro prediction of in vivo absorption of ibuprofen.pdf



6,34 MB
Adobe PDF
Compartir:


Creative Commons La licencia se describe como: Atribución-NonComercial-NoDerivada 4.0 Internacional.